AZN

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes

GlobeNewswire Inc. · 1d ago

Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ Deals

GlobeNewswire Inc. · 1d ago

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. · 3d ago

Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates

GlobeNewswire Inc. · 3d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN

GlobeNewswire Inc. · 4d ago

AstraZeneca Selloff Looks Larger Than the Wainua Valuation Damage

Investing.com · 8d ago

Physicians and Patients Agree Lupus Care Is Improving, But Both Say Meaningful Gaps Remain

GlobeNewswire Inc. · 11d ago

Transthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS Insider

GlobeNewswire Inc. · 11d ago

Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

GlobeNewswire Inc. · 25d ago

Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda

GlobeNewswire Inc. · 25d ago

Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight

GlobeNewswire Inc. · 26d ago

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire Inc. · 32d ago

This Aggressive Prostate Cancer Finally Has Targeted Treatment — AstraZeneca Wins FDA Nod

Benzinga · 33d ago

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials

Benzinga · 39d ago

MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth

GlobeNewswire Inc. · 39d ago

AstraZeneca Reports Significant Proteinuria Reduction With Ultomiris In Rare Kidney Disease

Benzinga · 40d ago

IEFA: Why This Fund Is One of the Best International ETFs

The Motley Fool · 44d ago

AstraZeneca Highlights Sustained Survival Benefit In Advanced Breast Cancer Study

Benzinga · 46d ago

AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial

Benzinga · 47d ago

Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million

The Motley Fool · 48d ago

ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight

GlobeNewswire Inc. · 59d ago

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

GlobeNewswire Inc. · 61d ago

Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight

GlobeNewswire Inc. · 61d ago

Studies Highlight Advances in Bladder Cancer Care and Emerging Environmental Risks

GlobeNewswire Inc. · 64d ago

SAPHNELO Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

GlobeNewswire Inc. · 64d ago